Increased plasma carbonylation has also been demonstrated in patients with type 2 diabetes as a strong predictor of reduced fibrinolytic efficiency, independent from plasminogen activator inhibitor-1 (PAI-1) [14]. The gene discussed is SERPINE1; the disease is type 2 diabetes mellitus.